Mephenamic acid, dactofenac sodium, piroxicam, tenoxicam and meloxicam
NSAID medicaments (mephenamic acid, piroxicam, meloxicam, tenoxicam)
HSN 3004 90 66 covers finished-dose NSAID medicaments — mephenamic acid, diclofenac sodium, piroxicam, tenoxicam and meloxicam — and is subject to Central Drugs Standard Control Organisation (CDSCO) import-licensing and drug-registration requirements under the Drugs and Cosmetics Act, 1940. The Directorate General of Foreign Trade (DGFT) classifies this tariff line as Restricted, and five mandatory documents must be uploaded in e-Sanchit before customs out-of-charge is granted.
- Import licence for drugs from CDSCO
- Registration certificate from CDSCO
- Batch release certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid import licence for drugs (document code 9111dc) and a current registration certificate for the specific drug (document code 101dc1) from CDSCO before the consignment is shipped. Both documents must be uploaded in e-Sanchit prior to filing the bill of entry.Drugs and Cosmetics Act, 1940 · e-Sanchit document codes 9111dc and 101dc1
- 2Upload the Certificate of Analysis for drugs (document code 0010dc), the batch release certificate (document code 0030dc), and the label of the consignment (document code 0110dc) in e-Sanchit before the bill of entry reaches the proper officer. Out-of-charge will not be granted until all five mandatory documents are verified in e-Sanchit.e-Sanchit document codes 0010dc, 0030dc, 0110dc · CDSCO import-clearance procedure
- 3Note that import of oxytocin is prohibited for this chapter; import of oxytocin reference standards is permitted exclusively for test and analysis against a test licence issued by DGCI/CDSCO. Ensure the consignment does not include prohibited molecules, as any misdeclaration renders the entire bill of entry liable to seizure and confiscation.S.O. 2357(E) · DGFT Notification 09/2015-2020 both dated 23-05-2022
The most common error on this tariff line is presenting a registration certificate that covers only the brand name or formulation variant approved for domestic manufacture, not the specific imported presentation. CDSCO registration must correspond exactly to the imported product's formulation, strength, and dosage form; a mismatch between the registration certificate and the bill of entry description triggers consignment detention and demurrage while a fresh CDSCO approval is sought — a process that can run to weeks.